BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593]
URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6593.htm
Number Citing Articles
1
Neha R Santucci, Miguel Saps, Miranda A van Tilburg. New advances in the treatment of paediatric functional abdominal pain disordersThe Lancet Gastroenterology & Hepatology 2020; 5(3): 316 doi: 10.1016/S2468-1253(19)30256-0
2
Kayle Dickson, Hajer Malitan, Christian Lehmann. Imaging of the Intestinal Microcirculation during Acute and Chronic InflammationBiology 2020; 9(12): 418 doi: 10.3390/biology9120418
3
Gisela Chelimsky, Pippa Simpson, Liyun Zhang, Doug Bierer, Steve Komas, Balaraman Kalyanaraman, Thomas Chelimsky, Takahiro Ushida. Impaired Mitochondrial Bioenergetics Function in Pediatric Chronic Overlapping Pain Conditions with Functional Gastrointestinal DisordersPain Research and Management 2021; 2021: 1 doi: 10.1155/2021/6627864
4
Robyn Rexwinkel, Arine M. Vlieger, Miguel Saps, Merit M. Tabbers, Marc A. Benninga. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specifiedEuropean Journal of Pediatrics 2022; 181(7): 2603 doi: 10.1007/s00431-022-04459-y
5
Dae Young Lee, Hee Eun Kang. Pharmacokinetics of DA-6886, A New 5-HT4 Receptor Agonist, in RatsPharmaceutics 2022; 14(4): 702 doi: 10.3390/pharmaceutics14040702
6
Emanuele Sinagra, Francesca Rossi, Dario Raimondo, Giuseppe Conoscenti, Andrea Anderloni, Valentina Guarnotta, Marcello Maida. Tenapanor for the treatment of irritable bowel syndrome with constipationExpert Review of Clinical Pharmacology 2020; 13(5): 473 doi: 10.1080/17512433.2020.1762570
7
Yong Li, Tingting Yang, Qing Yao, Songsong Li, En Fang, Yankun Li, Chao Liu, Weimin Li. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation‐induced IBS‐like ratsNeurogastroenterology & Motility 2019; 31(5): e13556 doi: 10.1111/nmo.13556
8
Christopher Tait, Gregory S. Sayuk. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventionsEuropean Journal of Internal Medicine 2021; 84: 1 doi: 10.1016/j.ejim.2020.12.023
9
M.A. Livzan, O.V. Gaus. Fecal zonulin as a biomarker of increased intestinal permeability in patients with irritable bowel syndrome (narrative review and pilot study results)Dokazatel'naya gastroenterologiya 2021; 10(3): 47 doi: 10.17116/dokgastro20211003147
10
M. A. Osadchuk, A. A. Svistunov, N. V. Kireeva, M. M. Osadchuk. Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problemTerapevticheskii arkhiv 2020; 92(2): 111 doi: 10.26442/00403660.2020.02.000458
11
Nils Günnewich, Thorsten Rose, Kathrin Koll, Kurt Appel. Magen-Darm-Entoxin® Shows Anti-Inflammatory Effects in vitroComplementary Medicine Research 2021; 28(5): 473 doi: 10.1159/000514525
12
Laura Beatrice Mattioli, Maria Frosini, Rosa Amoroso, Cristina Maccallini, Elda Chiano, Rita Aldini, Francesco Urso, Ivan Corazza, Matteo Micucci, Roberta Budriesi. Olea europea L. Leaves and Hibiscus sabdariffa L. Petals Extracts: Herbal Mix from Cardiovascular Network Target to Gut Motility Dysfunction ApplicationNutrients 2022; 14(3): 463 doi: 10.3390/nu14030463
13
Francesca Curci, Filomena Corbo, Maria Lisa Clodoveo, Lara Salvagno, Antonio Rosato, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Laura Beatrice Mattioli. Polyphenols from Olive-Mill Wastewater and Biological Activity: Focus on Irritable Bowel SyndromeNutrients 2022; 14(6): 1264 doi: 10.3390/nu14061264
14
Ilmaben S Vahora, Nicholas Tsouklidis, Rajat Kumar, Ravi Soni, Safeera Khan. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel SyndromeCureus 2020;  doi: 10.7759/cureus.9871
15
Lijun Mei, Jiaoli Zhou, Yimo Su, Kunhong Mao, Jing Wu, Caicai Zhu, Ling He, Ying Cui. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndromeBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01693-w
16
Xiao-Ya Li, Zhou-Jin Tan. Modern biological connotation of diarrhea with kidney-Yang deficiency syndromeWorld Chinese Journal of Digestology 2022; 30(3): 119 doi: 10.11569/wcjd.v30.i3.119
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
17
Yu Zhang, Lu Zhang, Shuang Li, Xia-Xin Wu, Ya-Xin Bi, Xu Hu, Yu-Qing Chen, Yuan Yuan. Serum levels of high sensitive C-reactive protein and tumor necrosis factor-alpha in different subtypes of irritable bowel syndrome and their correlationWorld Chinese Journal of Digestology 2020; 28(16): 782 doi: 10.11569/wcjd.v28.i16.782
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
18
L. B. Lazebnik, E. V. Golovanova, B. A. Volel, N. V. Korochanskaya, E. A. Lyalyukova, M. V. Mokshina, S. N. Mekhtiev, O. A. Mekhtieva, Z. V. Metsaeva, D. S. Petelin, V. I. Simanenkov, S. I. Sitkin, S. V. Cheremushkin, M. V. Chernogorova, А. I. Khavkin. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of RussiaExperimental and Clinical Gastroenterology 2021; (8): 5 doi: 10.31146/1682-8658-ecg-192-8-5-117
19
Uday C Ghoshal. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatmentJournal of Gastroenterology and Hepatology 2020; 35(5): 712 doi: 10.1111/jgh.15032
20
Andrea Anderloni, Fabio Pace, Carlo Fabbri, Gaetano Cristian Morreale, Erika Utzeri, Emanuele Sinagra. Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for cliniciansWorld Journal of Clinical Cases 2020; 8(6): 1013-1025 doi: 10.12998/wjcc.v8.i6.1013
21
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez, Alba García-López. Foundations of Colorectal Cancer2022; : 435 doi: 10.1016/B978-0-323-90055-3.00031-4
22
Yoshiharu Uno. Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel diseaseMedical Hypotheses 2019; 132: 109324 doi: 10.1016/j.mehy.2019.109324
23
Oscar J. Cordero, Rubén Varela-Calviño, Begoña Graña-Suárez. Cancer Immunology2020; : 261 doi: 10.1007/978-3-030-57949-4_10
24
Biljana Radovanovic-Dinic, Snezana Tesic-Rajkovic, Sasa Grgov, Gordana Petrovic, Valentina Zivkovic. Irritable bowel syndrome - from etiopathogenesis to therapyBiomedical Papers 2018; 162(1): 1 doi: 10.5507/bp.2017.057
25
Yu Zhang, Xia‐Xin Wu, Shuang Li, Jin‐Feng Wu, Sen Han, Zhi‐Jie Lin, Shi‐Zhen Ding, Wei‐Juan Gong. Peroxiredoxin 1 as an inflammatory marker in diarrhea‐predominant and postinfectious irritable bowel syndromeNeurogastroenterology & Motility 2020; 32(2) doi: 10.1111/nmo.13741
26
Vassilia Theodorou, Catherine Beaufrand, Sophie Yvon, Guylaine Laforge, Yvonne Burmeister, Andrea Müller, Bernd Seilheimer, Lionel Bueno, Helene Eutamene. The multicomponent medication Spascupreel attenuates stress‐induced gut dysfunction in ratsNeurogastroenterology & Motility 2020; 32(5) doi: 10.1111/nmo.13798
27
Tingting Cai, Xiang Wang, Bangjie Li, Fei Xiong, Hao Wu, Xinghao Yang. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringinPhytomedicine 2021; 86: 153527 doi: 10.1016/j.phymed.2021.153527